T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORC
2401
Orchid Island Capital
ORC
$1.32B
| $269K | ﹤0.01% |
25,586
-687
| -3% | -$7K |
|
2402
Emergent Biosolutions
EBS
$233M
| $268K | ﹤0.01% |
22,717
-5,422
| -19% | -$83.9K |
|
2403
Editas Medicine
EDIT
$432M
| $268K | ﹤0.01% |
30,227
-4,381
| -13% | -$48.1K |
|
2404
Sanara MedTech
SMTI
$316M
| $268K | ﹤0.01% |
+5,900
| New | +$203K |
|
2405
Atara Biotherapeutics
ATRA
$83.1M
| $267K | ﹤0.01% |
3,253
-1,025
| -24% | -$107K |
|
2406
Clean Energy Fuels
CLNE
$384M
| $267K | ﹤0.01% |
51,353
+2,983
| +6% | +$18.3K |
|
|
TPIC
2407
DELISTED
TPI Composites
TPIC
| $267K | ﹤0.01% |
26,354
+1,952
| +8% | +$20.3K |
|
2408
Harrow
HROW
$1.48B
| $266K | ﹤0.01% |
18,000
-800
| -4% | -$9.56K |
|
|
KRON
2409
DELISTED
Kronos Bio
KRON
| $265K | ﹤0.01% |
163,592
-7,594
| -4% | -$17.5K |
|
2410
Rocket Lab Corp
RKLB
$51.2B
| $265K | ﹤0.01% |
70,356
+8,472
| +14% | +$37K |
|
2411
Simulations Plus
SLP
$371M
| $265K | ﹤0.01% |
7,236
-2,574
| -26% | -$108K |
|
2412
Universal Technical Institute
UTI
$1.41B
| $265K | ﹤0.01% |
39,415
+208
| +0.5% | +$1.37K |
|
|
ICPT
2413
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $265K | ﹤0.01% |
21,436
+466
| +2% | +$6.6K |
|
2414
Blink Charging
BLNK
$85.6M
| $264K | ﹤0.01% |
24,024
+6,176
| +35% | +$84.2K |
|
2415
Frontline
FRO
$9.02B
| $264K | ﹤0.01% |
21,731
+1,626
| +8% | +$20.9K |
|
2416
iShares National Muni Bond ETF
MUB
$45.9B
| – | – |
0
| – | – |
|
|
CTO
2417
CTO Realty Growth
CTO
$819M
| $263K | ﹤0.01% |
14,382
+475
| +3% | +$9.12K |
|
2418
NWPX Infrastructure Inc
NWPX
$1.1B
| $263K | ﹤0.01% |
7,796
-2,242
| -22% | -$76.1K |
|
|
CSII
2419
DELISTED
Cardiovascular Systems, Inc.
CSII
| $262K | ﹤0.01% |
19,241
+931
| +5% | +$13K |
|
2420
Funko
FNKO
$331M
| $261K | ﹤0.01% |
23,921
+692
| +3% | +$9.71K |
|
|
MODN
2421
DELISTED
MODEL N, INC.
MODN
| $261K | ﹤0.01% |
6,447
+383
| +6% | +$14.4K |
|
|
EB
2422
DELISTED
Eventbrite
EB
| $260K | ﹤0.01% |
44,399
+1,733
| +4% | +$11.3K |
|
2423
MGP Ingredients
MGPI
$381M
| $260K | ﹤0.01% |
2,448
+188
| +8% | +$21K |
|
2424
Royal Bank of Canada
RY
$297B
| $260K | ﹤0.01% |
2,770
| – | – |
|
2425
Bank of N.T. Butterfield & Son
NTB
$2.5B
| $259K | ﹤0.01% |
8,683
+673
| +8% | +$22.2K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.